Ovarian Cancer | Consensus or Controversy? Current and Future Management of Ovarian Cancer

Featuring perspectives from Drs Ursula Matulonis and Debra Richardson, including the following topics:

• PROLOGUE: Antibody-Drug Conjugates Across Oncology (0:00)
• Antibody-Drug Conjugates in Ovarian Cancer: Mirvetuximab Soravtansine (10:03)
• Antibody-Drug Conjugates in Ovarian Cancer: Upifitamab Rilsodotin (29:09)
• Tumor Treating Fields (41:35)
• PARP Inhibitor Update (47:29)

CME information and select publications